- CSR Summary Not Available
- NCT02846545
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameGolimumabProduct NameSIMPONI®Therapeutic AreaImmune System DiseasesEnrollment84% Female41.7%% White85.7%
Product ClassAntirheumatic Agents - Biologic Response ModifiersSponsor Protocol NumberCNTO148DML2001Data PartnerJohnson & JohnsonCondition StudiedDiabetes Mellitus, Type 1Mean/Median Age (Years)13.4
Supporting Documentation
- Collected Datasets Available
- Statistical Analysis Plan Available
- Clinical Study Report Available